Pi-3k/Akt/Gsk-3 Beta Signaling Cascades Stimulated by Insulin Like Growth Factor-I Contribute to Multiple Myeloma Cells Proliferation and Survival
Wang Meng-chang,Fu Xue-de,Li Man-xiang
DOI: https://doi.org/10.1097/00029330-200607020-00018
IF: 6.133
2006-01-01
Chinese Medical Journal
Abstract:Multiple myeloma is characterized by the accumulation of malignant plasma cells in the bone marrow. Significant progress in molecular mechanisms of signaling pathways underlying the survival and/or proliferation of these cells has been achieved. Interleukin 6 (IL-6) is an important cytokine leading to multiple myeloma (MM) cells growth and survival.1,2 However, some MM cells isolated from MM patients are poorly responsive to IL-6 stimulation or IL-6 independent.3 This phenomenon raises the possibility that other growth factors may also be involved in the development of MM. Insulin like growth factor-I (IGF-I) plays an important role in the proliferation of a variety of cell types, in the development and growth of multiple tumors and in the prevention of apoptosis.4 IGF-I has recently been reported to play such a role in stimulating the MM cells growth,5,6 it even induces MM cells proliferation in IL-6 dependent cells,7 yet the detailed signaling components triggered by IGF-I have not been completely clarified. Thus, the present study are to address the signaling cascades triggered by IGF-I in MM cells. METHODS Cell culture MM cell lines (RPMI8226) were cultured in RPMI 1640 containing 10% heat-inactivated fetal calf serum (FCS), 2 mmol/L L-glutamine, penicillin (100 U/ml), and streptomycin (100 μg/ml) at 37°C in humidified 95% air and 5% CO2. Cells were switched to RPMI 1640 with 1% of FCS overnight before study. The role of PI-3K activation by IGF-I (100 ng/ml) was assessed by pre-treating cells with a selective PI-3K inhibitor LY294002 (20 μmol/L) for 1 hour before further study. Cells proliferation assay Cells (5×104) were cultured in 96-well plates in RPMI 1640 containing 1% FCS and stimulated by 100 ng/ml IGF-I for 48 hours at 37°C and 5% CO2 with or without pretreatment of PI-3K inhibitor LY294002 (20 μmol/L) for 1 hour. DNA synthesis was measured by [3H]-thymidine incorporation (3H-TdR). 3H-TdR (18.5 kBq) per well was added during the last 6 hours of culture. Cells were harvested and counted by means of beta plate scintillation counter. All experiments were performed in triplicate. Immunoblotting analysis Cells were lysed in buffer containing 50 mmol/L Tris-HCl (pH 7.4), 1% NP-40, 0.1% SDS, 150 mmol/L NaCl, 0.5% sodium-deoxycholate, 1 mmol/L EDTA, 1 mmol/L PMSF, 1 mmol/L Na3VO4, 1 mmol/L NaF and proteinase inhibitors. Protein concentration was measured by BCA protein assay kit (Pierce Inc, USA). Thirty μg of protein was separated on 8%-12% SDS gel and transfered onto nitrocellulose membrane. Polyclonal antibodies against Akt, p-Akt (Ser473), GSK-3β, p-GSK-3β (Ser9) (Cell signaling Inc, USA) were used according to manufacturer's recommended protocols. Horse-radish peroxidase-conjugated goat anti-rabbit IgG was used as secondary antibodies (Sigma, USA). The reactions were developed with chemiluminescent substrate and exposured to autoradiographic film. The intensity of signaling was quantified from scanned films using Scion NIH Image software (Scion, USA). Statistical analysis Results were expressed as mean ± standard deviations. Statistical significance was evaluated using Student's t test, P<0.05 was considered statistically significant. RESULTS IGF-I inducing PI-3K dependent phosphorylation of Akt and GSK-3β IGF-I induced a rapid Akt phosphorylation at Ser 473, peaked at 30 minutes and lasted for 2 hours in MM cells (Fig. 1). Based on this analysis, subsequent mechanisms study focused on 30 minutes time course. As showed in Fig. 2, IGF-I induced 4 fold increase in Akt phosphorylation at 30 minutes (P=0.009 vs control): the response was completely inhibited by pretreatment of cells with PI-3K inhibitor LY294002 (P=0.005 vs IGF-1 stimulated cells).Fig. 1.: IGF-I stimulates phosphorylation of Akt. MM cells were exposed to IGF-I (100 ng/ml) for time periods indicated, cell lysates were analyzed by Western blot with antibodies against phospho-Akt (Ser473) and total Akt. Akt phosphorylation peaked at 30 minutes. pAkt: phosphorylated Akt; tAkt: total Akt.Fig. 2.: PI-3K inhibitor blocks phosphorylation of Akt in response to IGF-I. MM cells were pre-treated with PI-3K inhibitor LY294002 (20 μmol/L) for 1 hour before stimulated by IGF-I (100 ng/ml) for 30 minutes. Phosphorylation of Akt was determined by Western blot as described in Fig. 1. Upper panel shows representative western blot (A). Lower bar graph (B) provides summarization of the ratio of phosphorylated/total Akt (n=3 each group). *P<0.01 versus control; #P<0.01 vs IGF-I.GSK-3β is a well-known downstream target of Akt which plays an important role in regulating cellular survival. Therefore, we next determined whether IGF-I also triggered the phosphorylation of GSK-3β. We found that IGF-I led to 2.2 fold increase in GSK-3β phosphorylation at Ser9 (P=0.006 vs control) (Fig. 3). Similar to Akt response, pre-treating cells with PI-3K inhibitor fully blocked GSK-3β phosphorylation (P=0.004 vs IGF-I stimulated cells). This indicated that GSK-3β coupled PI-3K/Akt signaling and mediated IGF-I effects.Fig. 3.: PI-3K inhibitor blocks phosphorylation of GSK-3β. Induced by IGF-I. MM cells were pretreated with PI-3K inhibitor LY294002 (20 μmol/L) for 1 hour before exposure to IGF-I (100 ng/ml) for 30 minutes. Phosphorylation of GSK-3β (Ser9) in cells lysates was detected by immunoblotting with specific phosphor-antibody. The same gel was re-probed with total GSK-3β. Representative blots (A) and quantitative analysis of protein phosphorylation (B) were shown. *P <0.01 versus control; #P <0.01 vs IGF-I.IGF-I stimulating proliferation of MM cells PI-3K/Akt/GSK-3β signaling has been shown to enhance multiple cells survival against apoptosis. Therefore, it is of interests to test the effects of IGF-I on proliferation and survival of MM cells. The average of basal 3H-TdR in MM cells is (42.7±3.9) CPU (41, 48, 39). 3H-TdR uptake increased to (173.7 ±29.4) CPU (210, 173, 138) upon IGF-I stimulation (Fig. 4, P=0.003 versus control). Furthermore, PI-3K inhibitor LY294002 fully abolished the response of MM cells to IGF-I, 3H-TdR uptake decreased to (52.3±5.3) CPU (46, 59, 52) again, suggesting that PI-3K signaling mediated the effect of IGF-I on MM cells growth.Fig. 4.: IGF-I induces proliferation of MM cells. MM cells were cultured in low serum medium containing IGF-I (100 ng/ml) for 48 hours with or without pretreatment of PI-3K inhibitor LY294002 (20 μmol/L) for 1 hour. Cells proliferation was determined by [3H]-thymidine uptake. Results are presented as mean ± SD (n = 3). *P <0.01 vs control; #P < 0.01 vs IGF-I.DISCUSSION We have shown that IGF-I serves as an important signaling stimuli for MM cells proliferation and survival. This is mediated by the activation of PI-3K/Akt and thereby GSK-3β phosphorylation. Inhibition of PI-3K blocked this response, supporting its central role to this stimulation. Here we provide novel evidence that IGF-I signaling may be another critical regulator of MM cells growth beyond IL-6, targeting this pathway may represent a new therapeutic avenue to MM. Akt is a ubiquitously expressed kinase that regulates receptor-ligand triggered signaling regulating cellular survival and apoptosis.8 Akt phosphorylation is primarily linked to PI-3K activation by G-protein coupled receptor (GPCR) and receptor tyrosin kinase signaling.9,10 Growth factors and GPCR agonists activate PI-3K to phosphorylate the inner membrane lipid. The resulting phospholipid products recruit both Akt and 3-phosphoinositide-dependent protein kinase1 (PDK1) translocate to membrane, leading to phosphorylation/activation of Akt. Activated Akt in turn phosphorylates its downstream targets contributing to cytoprotection and anti-apoptosis.9,10 Here, we showed that IGF-I functioned as an important stimulating factor of MM cells by activating PI-3K/Akt signaling. This is supported by the selective PI-3K inhibitor diminishing not only Akt activation but also DNA synthesis and cells proliferation. GSK-3β modulates cells survival by regulating the initiation factor eIF2B,11 the microtubule-associated protein Tau, transcription factors CREB, c-myc, c-jun12 and mitochondrial permeability transition.13 We demonstrated that GSK-3β, an apoptosis regulatory protein phosphorylated by Akt, was coupled tightly to PI-3K/Akt signaling in IGF-I stimulated MM cells. GSK-3β phosphorylation inactivation by Akt thus leads to cellular survival and growth. Although IL-6 has been shown to play a central role in survival and growth of MM cells, the fact that IL-6 antagonists failed to induce remissions in patients with MM in some clinical trials suggests the involvement of other growth factors in pathogenesis of MM.14 These IL-6 independent growth promoting pathways have been recognized and are under intensive study recently.7 The present finding may add new insights to the pathogenesis of MM and provide novel and effective treatment strategies in MM.